John M. Goldman

John M. Goldman (30 November 1938 – 24 December 2013) was a British haematologist, oncologist and medical researcher. A specialist in chronic myeloid leukaemia, Goldman conducted pioneering research into leukaemia treatment – he was instrumental in the development of bone marrow transplantation as a clinical method, and later in the development of the drug imatinib. He was also a prolific author of scientific papers, was involved with numerous medical charities and had a decades-long surgical career at Hammersmith Hospital, London. He also helped establish the World Marrow Donor Association in 1990, and served (at various different times) as the president of the International Society for Experimental Haematology, the European Group for Blood and Marrow Transplantation, the European Haematology Association and several other medical and scientific organisations.

From the late 1990s onwards, Goldman was instrumental in promoting the use of the anti-cancer drug imatinib, working to refine and expand its clinical usage as a targeted therapy. He retired from Hammersmith Hospital in 2004, but continued to work as an advocate and benefactor of cancer research and treatment in the developing world. During his career, he published over 700 scientific papers, and was the editor of the journal Bone Marrow Transplantation from 1985 until his death in December 2013.

Personal life Goldman was married to Jeannine Fuller; after divorcing her, he lived with Constance Shaw. He was survived by his three children: a daughter from his marriage to Fuller, and a daughter and son from his relationship with Shaw. Goldman was an avid reader of history and classic literature, travelled extensively overseas, and was a passionate skier.